Home LiteratureArticle Details
PMID: 1558416 Published · ppublish English Journal Article

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity.

Annals of surgery ·Vol. 215 ·No. 4 ·1992-04-00 ·Pages 356-62

Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M

Abstract

Forty critically ill surgical patients with documented infections were studied during their stay in an intensive care unit. Among these patients, 19 developed septic shock and 16 died, 9 of them from septic shock. Interleukin 1 beta (IL-1 beta), tumor necrosis factor (TNF alpha), and interleukin 6 (IL-6) were measured each day and every 1 or 2 hours when septic shock occurred. Although IL-1 beta was never found, TNF alpha was most often observed in the serum at a level under 100 pg/mL except during septic shock. During these acute episodes TNF alpha level reached several hundred pg/mL, but only for a few hours. In contrast, IL-6 was always increased in the serum of acutely ill patients (peak to 500,000 pg/mL). There was a direct correlation between IL-6 peak serum level and TNF alpha peak serum level during septic shock and between IL-6 serum level and temperature or C-reactive protein serum level. Moreover, IL-6 correlated well with APACHE II score, and the mortality rate increased significantly in the group of patients who presented with IL-6 serum level above 1000 pg/mL. Thus, IL-6 appears to be a good marker of severity during bacterial infection.

MeSH Terms
Adult Aged Aged, 80 and over Bacteremia/blood C-Reactive Protein/analysis Cause of Death Critical Illness Female Humans Interleukin-1/analysis Interleukin-6/analysis Male Middle Aged Severity of Illness Index Shock/blood Shock, Septic/blood Survival Rate Tumor Necrosis Factor-alpha/analysis
Chemicals
Interleukin-1 Interleukin-6 Tumor Necrosis Factor-alpha C-Reactive Protein
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Damas P
Department of Anesthesiology, University of Liège, Belgium.
Ledoux D
Nys M
Vrindts Y
De Groote D
Franchimont P
Lamy M
References (29)
29 references, click to expand
  1. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
    J Clin Invest. 1988 Jun;81(6):1925-37 PMID: 3384955
  2. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Nature. 1987 Dec 17-23;330(6149):662-4 PMID: 3317066
  3. Tumor necrosis factor mediates endotoxic effects in mice.
    Infect Immun. 1987 Jul;55(7):1622-5 PMID: 3596805
  4. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  5. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  6. APACHE II: a severity of disease classification system.
    Crit Care Med. 1985 Oct;13(10):818-29 PMID: 3928249
  7. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.
    FASEB J. 1991 Mar 1;5(3):338-43 PMID: 1825816
  8. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group.
    J Infect Dis. 1990 May;161(5):982-7 PMID: 2109023
  9. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Nature. 1990 Dec 6;348(6301):550-2 PMID: 2147233
  10. Interleukin-6: an overview.
    Annu Rev Immunol. 1990;8:253-78 PMID: 2188664
  11. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality.
    Surg Gynecol Obstet. 1990 Jan;170(1):32-8 PMID: 2294627
  12. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.
    J Infect Dis. 1990 Jan;161(1):79-84 PMID: 2295861
  13. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.
    Am Rev Respir Dis. 1990 Jan;141(1):94-7 PMID: 2297191
  14. Lymphokines.
    N Engl J Med. 1987 Oct 8;317(15):940-5 PMID: 2442611
  15. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
    J Clin Invest. 1989 Dec;84(6):2008-11 PMID: 2592570
  16. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
    J Exp Med. 1989 Jan 1;169(1):333-8 PMID: 2783334
  17. Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man.
    J Immunol. 1989 Apr 1;142(7):2321-4 PMID: 2784459
  18. The serum interleukin 6 response to elective surgery.
    Lymphokine Res. 1989 Summer;8(2):123-7 PMID: 2786596
  19. Increased plasma levels of interleukin-6 in sepsis.
    Blood. 1989 Oct;74(5):1704-10 PMID: 2790194
  20. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans.
    Crit Care Med. 1989 Oct;17(10):975-8 PMID: 2791581
  21. Detection of circulating tumor necrosis factor after endotoxin administration.
    N Engl J Med. 1988 Jun 9;318(23):1481-6 PMID: 2835680
  22. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.
    Lancet. 1987 Feb 14;1(8529):355-7 PMID: 2880163
  23. Serum levels of interleukin-6 and acute phase responses.
    Lancet. 1987 Oct 17;2(8564):921 PMID: 2889120
  24. Cytokine appearance in human endotoxemia and primate bacteremia.
    Surg Gynecol Obstet. 1988 Feb;166(2):147-53 PMID: 3122336
  25. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
    N Engl J Med. 1988 Aug 18;319(7):397-400 PMID: 3135497
  26. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
    J Clin Invest. 1988 Apr;81(4):1162-72 PMID: 3258319
  27. Functional discrimination between interleukin 6 and interleukin 1.
    Eur J Immunol. 1988 Oct;18(10):1535-40 PMID: 3263920
  28. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.
    Clin Exp Immunol. 1988 Feb;71(2):314-9 PMID: 3280187
  29. Cachectin: more than a tumor necrosis factor.
    N Engl J Med. 1987 Feb 12;316(7):379-85 PMID: 3543677
Article Info
Journal
Annals of surgery
Abbr.
Ann Surg
ISSN
0003-4932
Published
1992-04-00
Pages
356-62
Language
English
Region
United States
NLM ID
0372354
PMCID
PMC1242452
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]